
TY  - JOUR
TI  - Abstracts presented at the 30th Annual VCS Conference, San Diego, CA, USA, 29 October–1 November 2010
JO  - Veterinary and Comparative Oncology
VL  - 9
IS  - 1
SN  - 1476-5810
UR  - https://doi.org/10.1111/j.1476-5829.2010.00252.x
DO  - doi:10.1111/j.1476-5829.2010.00252.x
SP  - e1
EP  - e49
PY  - 2011
ER  - 

TY  - JOUR
TI  - Poster
JO  - Surgical Practice
JA  - Surgical Practice
VL  - 19
IS  - S1
SN  - 1744-1625
UR  - https://doi.org/10.1111/1744-1633.12147
DO  - doi:10.1111/1744-1633.12147
SP  - 19
EP  - 62
PY  - 2015
ER  - 

TY  - JOUR
TI  - Abstracts-Symposia
JO  - Alcoholism: Clinical and Experimental Research
JA  - Alcohol Clin Exp Res
VL  - 39
IS  - S1
SN  - 0145-6008
UR  - https://doi.org/10.1111/acer.12742
DO  - doi:10.1111/acer.12742
SP  - 250A
EP  - 307A
PY  - 2015
ER  - 

TY  - JOUR
TI  - Focused Workshops
JO  - European Journal of Neurology
JA  - Eur J Neurol
VL  - 26
IS  - S1
SN  - 1351-5101
UR  - https://doi.org/10.1111/ene.14021
DO  - doi:10.1111/ene.14021
SP  - 965
EP  - 989
PY  - 2019
ER  - 

TY  - JOUR
TI  - 44th Congress of the International Society of Paediatric Oncology (SIOP) 2012, London, United Kingdom, 5th–8th October, 2012 SIOP abstracts
JO  - Pediatric Blood & Cancer
JA  - Pediatr. Blood Cancer
VL  - 59
IS  - 6
SN  - 1545-5009
UR  - https://doi.org/10.1002/pbc.24295
DO  - doi:10.1002/pbc.24295
SP  - 965
EP  - 1152
PY  - 2012
ER  - 

TY  - JOUR
TI  - Posters (Abstracts 301–2389)
JO  - Hepatology
JA  - Hepatology
VL  - 68
IS  - S1
SN  - 0270-9139
UR  - https://doi.org/10.1002/hep.30257
DO  - doi:10.1002/hep.30257
SP  - 184
EP  - 1353
PY  - 2018
ER  - 

TY  - JOUR
TI  - Posters
JO  - Transplant International
JA  - Transpl Int
VL  - 28
IS  - S4
SN  - 0934-0874
UR  - https://doi.org/10.1111/tri.12702
DO  - doi:10.1111/tri.12702
SP  - 277
EP  - 846
PY  - 2015
ER  - 

TY  - JOUR
TI  - RSA ABSTRACTS
JO  - Alcoholism: Clinical and Experimental Research
VL  - 30
IS  - s1
SN  - 0145-6008
UR  - https://doi.org/10.1111/j.1530-0277.2006.00150.x
DO  - doi:10.1111/j.1530-0277.2006.00150.x
SP  - 7A
EP  - 234A
PY  - 2006
ER  - 

TY  - JOUR
AU  - Lecca, Davide
AU  - Raffaele, Stefano
AU  - Abbracchio, Maria P.
AU  - Fumagalli, Marta
TI  - Regulation and signaling of the GPR17 receptor in oligodendroglial cells
JO  - Glia
JA  - Glia
VL  - n/a
IS  - n/a
SN  - 0894-1491
UR  - https://doi.org/10.1002/glia.23807
DO  - doi:10.1002/glia.23807
KW  - GPR17
KW  - neuroinflammatory diseases
KW  - oligodendrocyte progenitors
KW  - remyelination
KW  - signal transduction
AB  - Abstract Remyelination, namely, the formation of new myelin sheaths around denuded axons, counteracts axonal degeneration and restores neuronal function. Considerable advances have been made in understanding this regenerative process that often fails in diseases like multiple sclerosis, leaving axons demyelinated and vulnerable to damage, thus contributing to disease progression. The identification of the membrane receptor GPR17 on a subset of oligodendrocyte precursor cells (OPCs), which mediate remyelination in the adult central nervous system (CNS), has led to a huge amount of evidence that validated this receptor as a new attractive target for remyelinating therapies. Here, we summarize the role of GPR17 in OPC function, myelination and remyelination, describing its atypical pharmacology, its downstream signaling, and the genetic and epigenetic factors modulating its activity. We also highlight crucial insights into GPR17 pathophysiology coming from the demonstration that oligodendrocyte injury, associated with inflammation in chronic neurodegenerative conditions, is invariably characterized by abnormal and persistent GPR17 upregulation, which, in turn, is accompanied by a block of OPCs at immature premyelinating stages. Finally, we discuss the current literature in light of the potential exploitment of GPR17 as a therapeutic target to promote remyelination.
ER  - 

TY  - JOUR
TI  - Joint Meeting of the Pathological Society of Great Britain and Ireland and the Dutch Pathological Society (NVvP). 1–4 July 2008. Hosted by the Department of Pathology and Tumour Biology, Leeds Institute of Molecular Medicine, University of Leeds. Abstracts.
JO  - The Journal of Pathology
JA  - J. Pathol.
VL  - 216
IS  - S1
SN  - 0022-3417
UR  - https://doi.org/10.1002/path.2447
DO  - doi:10.1002/path.2447
SP  - S1
EP  - S60
PY  - 2008
ER  - 

TY  - JOUR
TI  - Posters
JO  - Journal of Digestive Diseases
JA  - Journal of Digestive Diseases
VL  - 18
IS  - S1
SN  - 1751-2972
UR  - https://doi.org/10.1111/1751-2980.12518
DO  - doi:10.1111/1751-2980.12518
SP  - 15
EP  - 159
PY  - 2017
ER  - 

TY  - JOUR
AU  - Pitkänen, Asla
AU  - Henshall, David C.
AU  - Cross, J. Helen
AU  - Guerrini, Renzo
AU  - Jozwiak, Sergiusz
AU  - Kokaia, Merab
AU  - Simonato, Michele
AU  - Sisodiya, Sanjay
AU  - Mifsud, Janet
TI  - Advancing research toward faster diagnosis, better treatment, and end of stigma in epilepsy
JO  - Epilepsia
JA  - Epilepsia
VL  - 60
IS  - 7
SN  - 0013-9580
UR  - https://doi.org/10.1111/epi.16091
DO  - doi:10.1111/epi.16091
SP  - 1281
EP  - 1292
KW  - biobanks
KW  - biomarker
KW  - comorbidities
KW  - databases
KW  - delivery systems
KW  - disease-modification
KW  - e-health
KW  - epileptogenesis
KW  - genetics
KW  - personalized medicine
KW  - research strategy
KW  - stigma
KW  - therapy
PY  - 2019
AB  - Abstract Seven large European Union (EU)?funded epilepsy-related research projects joined forces in May 2018 in Brussels, Belgium, in a unique community building event?the epiXchange conference. During this conference, 170 investigators from the projects DESIRE, EpimiRNA, EPISTOP, EpiTarget, EpiXchange, and EpiPGX as well as the European Reference Network EpiCARE, met up with key stakeholders including representatives of the European Commission, patient organizations, commercial partners, and other European and International groups. The epiXchange conference focused on sharing and reviewing the advances made by each project in the previous 5 years; describing the infrastructures generated; and discussing the innovations and commercial applications across five thematic areas: biomarkers, genetics, therapeutics, comorbidities, and biobanks and resources. These projects have, in fact, generated major breakthroughs including the discovery of biofluid-based molecules for diagnosis, elucidating new genetic causes of epilepsy, creating advanced new models of epilepsy, and the pre-clinical development of novel compounds. Workshop-style discussions focused on how to overcome scientific and clinical challenges for accelerating translation of research outcomes and how to increase synergies between the projects and stakeholders at a European level. The resulting advances would lead toward a measurable impact of epilepsy research through better diagnostics, treatments, and quality-of-life for persons with epilepsy. In addition, epiXchange provided a unique forum for examining how the different projects could build momentum for future novel groundbreaking epilepsy research in Europe and beyond. This report includes the main recommendations that resulted from these discussions.
ER  - 

TY  - JOUR
TI  - Oral Presentations
JO  - Journal of Tissue Engineering and Regenerative Medicine
JA  - J Tissue Eng Regen Med
VL  - 8
IS  - s1
SN  - 1932-6254
UR  - https://doi.org/10.1002/term.1931
DO  - doi:10.1002/term.1931
SP  - 39
EP  - 206
PY  - 2014
ER  - 

TY  - JOUR
TI  - General abstracts (in alphabetical order by presenting underlined author)
JO  - American Journal of Reproductive Immunology
JA  - Am J Reprod Immunol
VL  - 76
IS  - S1
SN  - 1046-7408
UR  - https://doi.org/10.1111/aji.12581
DO  - doi:10.1111/aji.12581
SP  - 29
EP  - 62
PY  - 2016
ER  - 

TY  - JOUR
TI  - Abstracts of the IPITA-IXA-CTS 2015 Joint Congress November 15–19, 2015, Melbourne, Australia
JO  - Xenotransplantation
JA  - Xenotransplantation
VL  - 22
IS  - S1
SN  - 0908-665X
UR  - https://doi.org/10.1111/xen.12204
DO  - doi:10.1111/xen.12204
SP  - S2
EP  - S47
PY  - 2015
ER  - 

TY  - JOUR
TI  - Posters
JO  - The FEBS Journal
JA  - FEBS J
VL  - 284
IS  - S1
SN  - 1742-464X
UR  - https://doi.org/10.1111/febs.14174
DO  - doi:10.1111/febs.14174
SP  - 102
EP  - 403
PY  - 2017
ER  - 

TY  - JOUR
TI  - 144th Annual Meeting American Neurological Association
JO  - Annals of Neurology
JA  - Ann Neurol
VL  - 86
IS  - S24
SN  - 0364-5134
UR  - https://doi.org/10.1002/ana.25587
DO  - doi:10.1002/ana.25587
SP  - S1
EP  - S285
PY  - 2019
ER  - 

TY  - JOUR
AU  - Hou, Jiayin
AU  - Liu, Liang
AU  - Zhu, Qian
AU  - Wu, Yingbiao
AU  - Tian, Bei
AU  - Cui, Li
AU  - Liu, Ying
AU  - Li, Xinming
TI  - MicroRNA-185 inhibits angiogenesis in human microvascular endothelial cells through targeting stromal interaction molecule 1
JO  - Cell Biology International
JA  - Cell Biol Int
VL  - 40
IS  - 3
SN  - 1065-6995
UR  - https://doi.org/10.1002/cbin.10572
DO  - doi:10.1002/cbin.10572
SP  - 318
EP  - 328
KW  - angiogenesis
KW  - human microvascular endothelial cells
KW  - microRNA-185
KW  - stromal interaction molecule 1
PY  - 2016
AB  - Abstract Angiogenesis is a vital biological mechanism representing the adaptive response to a variety of pathological stimuli such as hypoxia. It is regulated by several pro-angiogenic and anti-angiogenic microRNAs. Studies have demonstrated an altered microRNA-185 (miR-185) expression in endothelial cells under hypoxic conditions; however, its role in angiogenesis has not been elucidated. We investigated the role of miR-185 in angiogenesis and found that miR-185 had an inhibitory effect on cell proliferation, migration, and tube formation. Stromal interaction molecule 1 (STIM1) appeared to be a direct target of miR-185 by computational prediction; this was confirmed by luciferase reporter assay. Silencing of the STIM1 gene was found to mimic miR-185-mediated inhibition of angiogenesis. STIM1 overexpression eliminated the anti-angiogenic effect of miR-185. Our study results suggest a direct interaction between miR-185 and STIM1 mRNA in microvascular endothelial cells. MicroRNA-185 acted as a negative regulator of angiogenesis in microvascular endothelial cells through downregulation of the STIM1 protein.
ER  - 

TY  - JOUR
TI  - Published Only
JO  - Journal of Digestive Diseases
JA  - Journal of Digestive Diseases
VL  - 16
IS  - S1
SN  - 1751-2972
UR  - https://doi.org/10.1111/1751-2980.12277
DO  - doi:10.1111/1751-2980.12277
SP  - 29
EP  - 146
PY  - 2015
ER  - 

TY  - JOUR
TI  - Poster Abstracts
JO  - American Journal of Transplantation
VL  - 11
IS  - s2
SN  - 1600-6135
UR  - https://doi.org/10.1111/j.1600-6143.2011.03534.x
DO  - doi:10.1111/j.1600-6143.2011.03534.x
SP  - 213
EP  - 527
PY  - 2011
ER  - 
